LOS ANGELES CAPITAL MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 182 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$855,996
-36.8%
54,280
-22.1%
0.00%
-20.0%
Q2 2023$1,354,657
-36.0%
69,684
-6.6%
0.01%
-44.4%
Q1 2023$2,116,828
+71.3%
74,615
+76.5%
0.01%
+50.0%
Q4 2022$1,235,727
-19.1%
42,276
+23.0%
0.01%
-25.0%
Q2 2022$1,527,000
-28.9%
34,358
-20.8%
0.01%0.0%
Q1 2022$2,148,000
+8.4%
43,394
+11.5%
0.01%
+14.3%
Q4 2021$1,982,000
-8.7%
38,918
-0.1%
0.01%
-30.0%
Q3 2021$2,172,000
+18.8%
38,939
-8.8%
0.01%
+25.0%
Q2 2021$1,828,000
+148.0%
42,709
+141.9%
0.01%
+166.7%
Q1 2021$737,000
-20.0%
17,659
-10.7%
0.00%
-25.0%
Q4 2020$921,000
-43.2%
19,774
-48.2%
0.00%
-42.9%
Q3 2020$1,621,000
-26.2%
38,149
-16.7%
0.01%
-36.4%
Q2 2020$2,197,000
+48.7%
45,786
+42.6%
0.01%
+22.2%
Q1 2020$1,477,000
+16.0%
32,105
+51.5%
0.01%
+50.0%
Q4 2019$1,273,000
+6.2%
21,1950.0%0.01%0.0%
Q3 2019$1,199,000
+46.8%
21,195
+44.5%
0.01%
+50.0%
Q2 2019$817,000
+10.4%
14,6650.0%0.00%0.0%
Q1 2019$740,000
+25.2%
14,6650.0%0.00%0.0%
Q4 2018$591,000
-32.1%
14,665
+16.9%
0.00%
-20.0%
Q3 2018$870,00012,5500.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 400,000$5,732,0001.52%
Park West Asset Management LLC 426,900$6,117,0000.80%
WALL STREET ASSOCIATES 200,000$2,866,0000.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 284,653$4,079,0000.16%
FARALLON CAPITAL MANAGEMENT LLC 100,000$1,433,0000.02%
NEXT Financial Group, Inc 2,500$26,0000.01%
PIPER SANDLER & CO. 1,277$18,0000.01%
Ground Swell Capital, LLC 400$6,0000.01%
PARADIGM ASSET MANAGEMENT CO LLC 6,300$90,279,0000.01%
Paloma Partners Management Co 14,363$206,0000.01%
View complete list of EAGLE PHARMACEUTICALS INC shareholders